Basic Search
|
Summaries
|
Advanced Search
Violation Tracker UK Individual Case
Company: Auden Mckenzie (Pharma Division) Ltd. and Accord-UK Ltd.
Current Parent Company:
Intas Pharmaceuticals Ltd.
Penalty: £2,882,238
Year: 2020
Date: 4 March, 2020
Offence Group: competition-related offences
Offence Type: price-fixing or anti-competitive practices
Violation Description: Auden Mckenzie and Accord-UK agreed to pay a £1,882,228 fine and make a payment of £1,000,000 to the NHS in settlement of a decision by the CMA that the companies had illegally colluded with King, another supplier of the drug nortriptyline, to fix prices and supply. King also paid a fine in settlement of the decision.
Action Type: agency action
Settlement Type: Settlement with the CMA
Case Number: 50507.2
Agency: Competition and Markets Authority
HQ Country of Parent: India
Ownership Structure of Parent: privately held
Major Industry of Parent: pharmaceuticals
Specific Industry of Parent: pharmaceuticals
Source of Data:
(click here)